MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
Biological: filgrastim
First Posted Date
2004-04-22
Last Posted Date
2016-07-01
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
29
Registration Number
NCT00002501
Locations
🇺🇸

State University of New York - Upstate Medical University, Syracuse, New York, United States

🇺🇸

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States

🇺🇸

Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States

and more 12 locations

Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Dietary Supplement: green tea extract
First Posted Date
2004-04-20
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
54
Registration Number
NCT00005828
Locations
🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

CCOP - Duluth, Duluth, Minnesota, United States

🇺🇸

Medcenter One Health System, Bismarck, North Dakota, United States

and more 13 locations

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2004-04-19
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
40
Registration Number
NCT00005810
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

🇺🇸

UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 4 locations

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
Metastatic Cancer
Interventions
First Posted Date
2004-04-14
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
44
Registration Number
NCT00003834
Locations
🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

CCOP - Duluth, Duluth, Minnesota, United States

🇺🇸

CentraCare Clinic, Saint Cloud, Minnesota, United States

and more 18 locations

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
Breast Cancer
Lung Cancer
Veno-occlusive Disease
Prostate Cancer
Interventions
Drug: standard therapy
First Posted Date
2004-04-14
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
141
Registration Number
NCT00003674
Locations
🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

🇺🇸

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 17 locations

Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Drug: nitrocamptothecin
First Posted Date
2004-04-12
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
35
Registration Number
NCT00005820
Locations
🇺🇸

CCOP - Christiana Care Health Services, Wilmington, Delaware, United States

🇺🇸

Walter Reed Army Medical Center, Washington, District of Columbia, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

and more 47 locations

Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
Procedure: therapeutic thoracoscopy
Procedure: video-assisted surgery
First Posted Date
2004-04-09
Last Posted Date
2023-08-18
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
128
Registration Number
NCT00003692
Locations
🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States

🇺🇸

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

and more 112 locations

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Phase 2
Terminated
Conditions
Colorectal Cancer
Interventions
Radiation: radiation therapy
Procedure: surgery
First Posted Date
2004-04-08
Last Posted Date
2016-12-15
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
3
Registration Number
NCT00081224

Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

First Posted Date
2004-04-08
Last Posted Date
2016-12-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
14
Registration Number
NCT00080951

Creatine in Treating Patients With Cancer-Associated Weight Loss

Phase 3
Completed
Conditions
Anorexia
Cachexia
Unspecified Adult Solid Tumor, Protocol Specific
Weight Changes
Interventions
Other: placebo
Dietary Supplement: creatine monohydrate
First Posted Date
2004-04-08
Last Posted Date
2020-04-29
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
300
Registration Number
NCT00081250
Locations
🇺🇸

Swedish Medical Center, Englewood, Colorado, United States

🇺🇸

St. James Healthcare Cancer Care, Butte, Montana, United States

🇺🇸

Guardian Oncology and Center for Wellness, Missoula, Montana, United States

and more 214 locations
© Copyright 2025. All Rights Reserved by MedPath